CTKB Q4 2025 Earnings — Cytek Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

CTKBCytek Biosciences, Inc.

$553M

Q4 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$62M+8.1% YoY

Gross Profit

$33M52.9% margin

Operating Income

-$6M-9.0% margin

Net Income

-$44M-70.9% margin

EPS (Diluted)

$-0.34

QoQ Revenue Growth

+18.8%

Cash Flow

Operating Cash Flow

-$771,000

Free Cash Flow

-$2M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$462M

Total Liabilities

$120M

Stockholders' Equity

$342M

Cash & Equivalents

$91M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$62M	$57M	+8.1%
Gross Profit	$33M	$34M	-2.3%
Operating Income	-$6M	$3M	-287.3%
Net Income	-$44M	$10M	-557.1%

Revenue Segments

Product

$47M100%

Geographic Segments

UNITED STATES

$26M41%

EMEA

$20M32%

Asia Pacific

$13M21%

Other

$4M6%